MedTrace Logo

Evaluation of the Phased Radio Frequency Ablation System

NCT01693120 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 199

Last updated 2025-02-13

Study results available
· View outcomes & findings →

Summary

VICTORY AF is an IDE, prospective global, multi-center, single arm, controlled, unblinded, investigational clinical study. The purpose of this clinical study is to evaluate the risk of procedure and/or device related strokes in subjects with persistent or long-standing persistent atrial fibrillation (AF) undergoing ablation with the Phased RF System.

Conditions

  • Persistent Atrial Fibrillation

Interventions

DEVICE

Medtronic Phased RF Ablation System

Phased RF ablation

Sponsors & Collaborators

  • Medtronic Cardiac Ablation Solutions

    lead INDUSTRY

Principal Investigators

  • John Hummel, MD · Ohio State University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2017-02-07
Completion
2017-02-07

Countries

  • United States
  • Canada
  • Hungary
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01693120 on ClinicalTrials.gov